Emerging Policy Response Resources / Tariffs

Tariff-related Litigation Update – 6/27

Member-only overview of IEEPA reciprocal & “fentanyl” tariffs under EO 14257, summarizing key federal court challenges and rulings through June 17, 2025.

Emerging Policy Response Resources / Tariffs

Tariff-related Litigation Update – 6/20

Member-only summary of IEEPA “fentanyl” and reciprocal tariffs under EO 14257, plus status of related legal challenges across federal courts through June 17, 2025.

Emerging Policy Response Resources / Tariffs

Tariff-related Litigation Update

Explore the latest IEEPA tariff developments and legal challenges, including executive orders on fentanyl tariffs and reciprocal duties affecting global MedTech trade.

Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Tariffs

Medtech is Essential: Industry Supports Call for Tariff Flexibility 

AdvaMed President and CEO Scott Whitaker testified before the U.S. Senate Finance Committee, bringing attention to the pressing issue of how tariffs could impact the medtech industry and, most importantly,…

Emerging Policy Response Resources / Global & Trade / Government & Legislative Affairs / Tariffs

AdvaMed Testifies in U.S. Senate 

WASHINGTON – Today, President and CEO Scott Whitaker of AdvaMed, the Medtech Association, testified before the U.S. Senate Committee on Finance in its hearing focused on the impact of tariffs…